Prion Diseases Section
Laboratory Details
The Prion Diseases Section provides national reference services in support of health care professionals dealing with suspected cases of Creutzfeldt-Jakob Disease (CJD). Accredited testing to detect the presence of the pathogenic prion protein in CSF is performed by the end-point quaking-induced conversion (EP- QuIC) test. A neuropsychiatric disorder plus positive EP-QuIC in cerebrospinal fluid (CSF) or other tissues is sufficient criteria for a diagnosis of probable CJD.
The Prion Diseases Section supports further investigation of CJD cases by providing genetic sequence analysis of PRNP (the gene encoding the prion protein). Sequence analyses confirm or exclude the presence of mutations linked to inherited prion diseases. Due to the privacy considerations surrounding sequencing of patient DNA, consent must be obtained prior to this analysis being performed. Consent forms are available through the CJD Surveillance System by phone: 1-888-489-2999, fax: 613-952-6668 or email: cjdsurveillance@phac-aspc.gc.ca
Proficiency Panels
Proficiency Panel Reports
Requisition Form
04-Follow-up Genetic Analysis Requisition (Blood Draw)
04-PDP-PRNP Gene-Blood-requisition-ENG.pdf
01-Initial EP-QuIC Test Requisition (LP for CSF)
01-PDP-CSF-requisition.pdf
05-Blood Shipping Instructions
05-Blood Shipping Protocol - Protocole d'expédition de sang.pdf
02-CSF Shipping Instructions
02-CSF Shipping Protocol - Protocole d'expédition du LCR.pdf
03-EP-QuIC Guide to Interpretation
03-EP-QuIC Guide to Interpretation.pdf
06-Post-Mortem Prion Protein Analysis Requisition (Brain Tissue)
06-PDP-Brain Tissue-requisition.pdf